HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vicente Alfaro Selected Research

PM 00104

8/2014Phase I study of carboplatin in combination with PM00104 (Zalypsis®) in patients with advanced solid tumors.
4/2014Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimen.
2/2014A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors.
6/2013Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vicente Alfaro Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 10/2004
9Neutropenia
09/2015 - 05/2007
6Nausea
01/2022 - 10/2013
6Fatigue
11/2021 - 05/2009
4Vomiting
01/2022 - 10/2013
4Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 11/2011
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2021 - 01/2020
3Neoplasm Metastasis (Metastasis)
12/2020 - 10/2004
3Thrombocytopenia (Thrombopenia)
01/2017 - 06/2013
3Sarcoma (Soft Tissue Sarcoma)
04/2014 - 06/2012
3Ischemia
11/2008 - 11/2002
2Breast Neoplasms (Breast Cancer)
11/2018 - 08/2017
2Febrile Neutropenia
06/2013 - 09/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2012 - 10/2004
1Endometrial Neoplasms (Endometrial Cancer)
11/2021
1Inflammation (Inflammations)
11/2021
1Disease Progression
01/2020
1Multiple Myeloma
09/2019
1Erythema
01/2017
1Lymphoma (Lymphomas)
01/2017
1Mucositis
09/2015
1Anemia
09/2015
1Triple Negative Breast Neoplasms
08/2014
1Carcinoma (Carcinomatosis)
04/2014
1Anorexia
04/2014
1Ewing Sarcoma (Sarcoma, Ewing)
02/2014
1Diarrhea
06/2013
1Genetic Translocation (Chromosomal Translocation)
11/2012
1Liver Diseases (Liver Disease)
09/2012
1Rhabdomyolysis
06/2012
1Acute Kidney Injury (Acute Renal Failure)
06/2012
1Adenocarcinoma
05/2012
1Myalgia
01/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2011
1Cardiotoxicity
01/2011
1Hypokalemia
01/2011
1Colorectal Neoplasms (Colorectal Cancer)
05/2007
1Pathologic Processes
03/2006
1Type 2 Diabetes Mellitus (MODY)
06/2003
1Hypertension (High Blood Pressure)
06/2003
1Proteinuria
06/2003
1Diabetic Nephropathies (Diabetic Nephropathy)
06/2003

Drug/Important Bio-Agent (IBA)

12TrabectedinIBA
08/2017 - 05/2007
8PM 01183IBA
01/2022 - 11/2018
6PlatinumIBA
11/2021 - 10/2004
4Pharmaceutical PreparationsIBA
06/2021 - 10/2004
4PM 00104IBA
08/2014 - 06/2013
4Transaminases (Aminotransferases)IBA
10/2013 - 05/2007
31-dodecylpyridoxal (PLD)IBA
11/2021 - 11/2011
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 04/2014
3Paclitaxel (Taxol)FDA LinkGeneric
06/2021 - 05/2010
3plitidepsin (aplidine)IBA
09/2019 - 01/2011
3Alanine Transaminase (SGPT)IBA
01/2017 - 05/2007
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 10/2013
2liposomal doxorubicin (Doxil)FDA Link
11/2021 - 09/2015
2DepsipeptidesIBA
01/2017 - 01/2011
2elisidepsinIBA
08/2015 - 05/2012
2DNA (Deoxyribonucleic Acid)IBA
11/2012 - 05/2009
2Creatine Kinase (Creatine Phosphokinase)IBA
06/2012 - 05/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2006 - 11/2002
1Aprepitant (Emend)FDA Link
01/2022
1Topotecan (Hycamtin)FDA LinkGeneric
11/2021
1Irinotecan (Camptosar)FDA LinkGeneric
06/2021
1Bortezomib (Velcade)FDA Link
09/2019
1Thalidomide (Thalomid)FDA Link
09/2019
1Lenalidomide (CC 5013)FDA Link
09/2019
1Dexamethasone (Maxidex)FDA LinkGeneric
09/2019
1Biomarkers (Surrogate Marker)IBA
11/2018
1Proteins (Proteins, Gene)FDA Link
11/2018
1Alkylating AgentsIBA
08/2017
1GemcitabineFDA Link
01/2017
1Sorafenib (BAY 43-9006)FDA Link
01/2017
1Bevacizumab (Avastin)FDA Link
08/2014
1Carboplatin (JM8)FDA LinkGeneric
08/2014
1Troponin IIBA
04/2014
1AlkaloidsIBA
02/2014
1AntiemeticsIBA
10/2013
1Lipase (Acid Lipase)FDA Link
06/2013
1Transcription Factors (Transcription Factor)IBA
11/2012
1cyclo(Arg-Pro) (CI 4)IBA
11/2012
1Oncogene Proteins (Oncogene Protein)IBA
11/2012
1Alkaline PhosphataseIBA
09/2012
1Hemoglobins (Hemoglobin)IBA
01/2011
1Lipocalin-2IBA
11/2008
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2007
1Protein Isoforms (Isoforms)IBA
03/2006
1Nitric Oxide Synthase (NO Synthase)IBA
03/2006
1Gefitinib (Iressa)FDA Link
10/2004
1ErbB Receptors (EGF Receptor)IBA
10/2004
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2004
1candesartanIBA
06/2003
1AlbuminsIBA
06/2003
1Angiotensin Receptor AntagonistsIBA
06/2003
1NucleotidesIBA
11/2002
1Adenosine (Adenocard)FDA LinkGeneric
11/2002
1XanthineIBA
11/2002

Therapy/Procedure

6Drug Therapy (Chemotherapy)
12/2020 - 10/2004
5Intravenous Infusions
01/2020 - 05/2007
5Therapeutics
01/2020 - 10/2013
1Treatment Delay
05/2010